Brouillet, Emmanuel
Centre National de la Recherche Scientifique · Commissariat à l'Énergie Atomique et aux Énergies Alternatives · Université Paris-Saclay · Laboratoire des Maladies Neurodégénératives · Molecular Imaging Research Center
13 papers on CoChatORCID 0000-0001-6322-7403
Most cited papers
- Verified
Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid
Brouillet, E., Jenkins, B. G., Hyman, B. T., Ferrante, R. J., Kowall, N. W., Srivastava, R., Roy, D. S., Rosen, B. R., & Beal, M. F. (1993) · Journal of Neurochemistry
Genetic Neurodegenerative DiseasesMitochondrial Function and Pathology
Cited by 367
- Verified
The JAK/STAT3 pathway is a common inducer of astrocyte reactivity in Alzheimer’s and Huntington’s diseases
Ben Haim, L., Ceyzériat, K., Carrillo-de Sauvage, M. A., Aubry, F., Auregan, G., Guillermier, M., Ruiz, M., Petit, F., Houitte, D., Faivre, E., et al. (2015) · The Journal of Neuroscience
Neuroinflammation and Neurodegeneration MechanismsCytokine Signaling Pathways and Interactions
Cited by 335
- Verified
Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer’s disease
Ceyzériat, K., Ben Haim, L., Denizot, A., Pommier, D., Matos, M., Guillemaud, O., Palomares, M.-A., Abjean, L., Petit, F., Gipchtein, P., et al. (2018) · Acta Neuropathologica Communications
Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments
Cited by 256
- Verified
Cannabinoid CB2receptor agonists protect the striatum against malonate toxicity: Relevance for Huntington's disease
Sagredo, O., González, S., Aroyo, I., Pazos, M. R., Benito, C., Lastres‐Becker, I., Romero, J. P., Tolón, R. M., Mechoulam, R., Brouillet, E., et al. (2009) · Glia
Cannabis and Cannabinoid ResearchNeuroinflammation and Neurodegeneration Mechanisms
Cited by 201
- Verified
Dopamine Gene Therapy for Parkinson’s Disease in a Nonhuman Primate Without Associated Dyskinesia
Jarraya, B., Boulet, S., Scott Ralph, G., Jan, C., Bonvento, G., Azzouz, M., Miskin, J. E., Shin, M., Delzescaux, T., Drouot, X., et al. (2009) · Science Translational Medicine
Parkinson's Disease Mechanisms and TreatmentsVirus-based gene therapy research
Cited by 186
- Verified
Engineered lentiviral vector targeting astrocytes In vivo
Colin, A., Faideau, M., Dufour, N., Auregan, G., Hassig, R., Andrieu, T., Brouillet, E., Hantraye, P., Bonvento, G., & Déglon, N. (2009) · Glia
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 158
- Verified
Diffusion-weighted magnetic resonance spectroscopy enables cell-specific monitoring of astrocyte reactivity in vivo
Ligneul, C., Palombo, M., Hernández-Garzón, E., Carrillo-de Sauvage, M.-A., Flament, J., Hantraye, P., Brouillet, E., Bonvento, G., Escartin, C., & Valette, J. (2019) · NeuroImage
Advanced MRI Techniques and ApplicationsAdvanced Neuroimaging Techniques and Applications
Cited by 77
- Verified
The striatal kinase DCLK3 produces neuroprotection against mutant huntingtin
Galvan, L., Francelle, L., Gaillard, M.-C., de Longprez, L., Carrillo-de Sauvage, M.-A., Liot, G., Cambon, K., Stimmer, L., Luccantoni, S., Flament, J., et al. (2018) · Brain
Genetic Neurodegenerative DiseasesGenetics and Neurodevelopmental Disorders
Cited by 47
- Verified
In vivo bidirectional modulatory effect of benzodiazepine receptor ligands on GABAergic transmission evaluated by positron emission tomography in non-human primates
Brouillet, E., Chavoix, C., Bottlaender, M., Khalili-Varasteh, M., Hantraye, P., Fournier, D., Dodd, R. H., & Mazière, M. (1991) · Brain Research
Neuroscience and Neuropharmacology ResearchReceptor Mechanisms and Signaling
Cited by 37
- Verified
THY-Tau22 mouse model accumulates more tauopathy at late stage of the disease in response to microglia deactivation through TREM2 deficiency
Vautheny, A., Duwat, C., Aurégan, G., Joséphine, C., Hérard, A.-S., Jan, C., Mitja, J., Gipchtein, P., Gaillard, M.-C., Buée, L., et al. (2021) · Neurobiology of Disease
Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms
Cited by 28
- Verified
Aminooxyacetic acid striatal lesions attenuated by 1,3-butanediol and coenzyme Q10
Brouillet, E., Henshaw, D. R., Schulz, J. B., & Beal, M. F. (1994) · Neuroscience Letters
Parkinson's Disease Mechanisms and TreatmentsCoenzyme Q10 studies and effects
Cited by 23
- Verified
In Vivo High Intrinsic Efficacy of Triazolam: A Positron Emission Tomography Study in Nonhuman Primates
Bottlaender, M., Brouillet, E., Varastet, M., Le Breton, C., Schmid, L., Fuseau, C., Sitbon, R., Crouzel, C., & Mazière, M. (1994) · Journal of Neurochemistry
Neuroscience and Neuropharmacology ResearchSynthesis and pharmacology of benzodiazepine derivatives
Cited by 17
- Verified
Coupling of D2R Short but not D2R Long receptor isoform to the Rho/ROCK signaling pathway renders striatal neurons vulnerable to mutant huntingtin
Galan‐Rodriguez, B., Martin, E., Brouillet, E., Déglon, N., Betuing, S., & Caboche, J. (2017) · European Journal of Neuroscience
Genetic Neurodegenerative DiseasesReceptor Mechanisms and Signaling
Cited by 5
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free